Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
about
Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination SurveyPersonalized medicine: hope or hype?Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanismsGenome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)Clinical assessment incorporating a personal genomeLipoprotein(a) as a cardiovascular risk factor: current statusThe role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleLipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature reviewPersonalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsFamilial hypercholesterolemia: an under-recognized but significant concern in cardiology practiceCurrent therapies for lowering lipoprotein (a)New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugsGenetics of lipid traits and relationship to coronary artery diseaseGenome-wide association studies of late-onset cardiovascular diseaseGenetics of the acute coronary syndromeMendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the futureMendelian Randomization and Type 2 DiabetesNew Era of Lipid-Lowering DrugsImpact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trialsHuman Genetics and the Causal Role of Lipoprotein(a) for Various DiseasesThe Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic TargetsAssociations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) StudyA comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery diseasePCSK9 Inhibition With Monoclonal Antibodies: Modern Management of HypercholesterolemiaLipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causalityTranslating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitineLarge-scale gene-centric analysis identifies novel variants for coronary artery diseaseGenetic variation in the human brain dopamine system influences motor learning and its modulation by L-DopaRare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWFPopulation genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) ConsortiumAssociation between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humansLarge-scale candidate gene analysis of HDL particle featuresLarge-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk ReductionMendelian randomization in cardiometabolic disease: challenges in evaluating causality.The Role of Emerging Risk Factors in Cardiovascular OutcomesEmerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyCausal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.
P2860
Q21135561-C4ABC00E-09D7-4EB5-B0AA-82C869710ED7Q24289193-5E94A578-EF58-40D3-847E-59246BC78A12Q24294266-82681382-C911-4434-88BF-059A98D30EFEQ24594382-F84E9A95-E148-4D32-8F1C-908C1CCE201EQ24612653-318BF4C4-CB20-4117-BD72-89EFB102AB6BQ24623225-63640313-CC5F-4267-BBBF-3A1C794BD89CQ24632581-CF012A79-F726-4569-9D43-9DC77E3C8DE1Q26747100-B54BCD33-3612-4ED4-8513-00EBC7E00561Q26771862-FAF1CBCD-6B68-4A0E-8491-A0D44E39E251Q26822796-BCA1885C-AC9C-4373-9428-61DA0D7A2EB7Q26828401-A94B4807-8C2A-4441-AFF5-9CF61E4C58D4Q26830297-B014F99D-5090-4F88-AD63-89A697E6D6FEQ26863369-28347CB3-9F70-400A-8834-9D9DCBFD432EQ26995252-DAADD985-BF74-4926-95A7-E72B1A5440BAQ27012711-D9D83117-6CFF-4CD8-9FF3-0235CC471C96Q28066981-9E337F7C-42AC-4EA4-9953-0F993A51A8C2Q28070061-C69483A9-7A8F-48C2-AC8B-79B686C184A7Q28072229-1C9B4E92-FE3A-42EC-AFDE-51055B78F623Q28072298-543C4321-4C78-40E1-A28A-93D4ADAF99D5Q28077742-AEF42D2E-C043-4FB6-B416-12275712BB1AQ28079294-2C1E899C-FEF5-4C95-BAC3-87F89B947B3CQ28080690-FD7B6391-F58A-43F2-8E1E-09D2016B9642Q28254321-50E6C45F-26D7-47D0-90B5-B77DA723FBDAQ28267020-3859110A-509D-4F0A-AB6D-972C6109FD39Q28275648-D52E6CD6-7AB6-47B0-8F9B-81E50EFD0D5DQ28303150-FBDC6E1B-BDAF-4C8F-BC77-FA8FF806D88FQ28395286-E82901AE-4345-4C1A-B967-65D7096DDEA8Q28477187-42FAEF58-CB1F-47A0-B54F-D20CF1CBE429Q28486256-8ED8150D-92A6-444E-AAAB-C5A056938A29Q28607764-665EBA03-575F-4383-B048-C34893013CB7Q28681745-577D334D-B461-41A0-86A6-19D25D5DB34CQ28740387-4333E953-786B-4D10-A96F-998FD7587B4FQ28743354-28576110-C7DD-42D4-9166-31E302C0B1EBQ29417023-151DDEA2-3807-4E61-98C5-BE0C93CA4E4CQ29999973-3CA9EA76-2A2E-4341-AA6C-7847EE0382D7Q30234302-98A36DC9-03D4-4B69-B97F-174342F04743Q30234550-A15F70B3-8BE2-4987-996F-F8A3BE33BBFBQ30234679-6F93D625-0035-4D04-8EF7-128BE6907808Q30242031-96CBDD11-B918-47EC-8BFA-15349BF4D9EBQ30411394-A19653C5-3A39-4C0C-AE2D-BF0F91F9E610
P2860
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Genetic variants associated with Lp
@nl
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
@en
type
label
Genetic variants associated with Lp
@nl
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
@en
prefLabel
Genetic variants associated with Lp
@nl
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
@en
P2093
P50
P356
P1476
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
@en
P2093
Angela Silveira
Bruna Gigante
Derrick Bennett
Fiona R Green
Jemma C Hopewell
John F Peden
Maria Grazia Franzosi
Martin Farrall
PROCARDIS Consortium
P304
P356
10.1056/NEJMOA0902604
P407
P50
P577
2009-12-01T00:00:00Z